{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:01:44Z","timestamp":1791270104338,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T00:00:00Z","timestamp":1471651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100013278","name":"JPND","doi-asserted-by":"crossref","award":["01ED1201A"],"award-info":[{"award-number":["01ED1201A"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer-Forschungs-Initiative e.V.","award":["12851"],"award-info":[{"award-number":["12851"]}]},{"DOI":"10.13039\/501100005224","name":"DZNE","doi-asserted-by":"crossref","award":["MiGAP"],"award-info":[{"award-number":["MiGAP"]}],"id":[{"id":"10.13039\/501100005224","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00415-016-8259-0","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T07:04:17Z","timestamp":1471676657000},"page":"2271-2277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cerebrospinal \u03b1-synuclein in \u03b1-synuclein aggregation disorders: tau\/\u03b1-synuclein ratio as potential biomarker for dementia with Lewy bodies"],"prefix":"10.1007","volume":"263","author":[{"given":"Franc","family":"Llorens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Varges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Gotzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Gmitterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,20]]},"reference":[{"issue":"5","key":"8259_CR1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neurol.2015.02.007","volume":"171","author":"E Boutin","year":"2015","unstructured":"Boutin E, Vaugoyeau M, Eusebio A, Azulay JP, Witjas T (2015) News and controversies regarding essential tremor. Rev Neurol (Paris) 171(5):415\u2013425","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"8259_CR2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/089198878800100106","volume":"1","author":"JL Cummings","year":"1988","unstructured":"Cummings JL (1988) Intellectual impairment in Parkinson\u2019s disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1(1):24\u201336","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"8259_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/CCLM.2011.077","volume":"49","author":"M Eller","year":"2011","unstructured":"Eller M, Williams DR (2011) alpha-Synuclein in Parkinson disease and other neurodegenerative disorders. Clin Chem Lab Med 49(3):403\u2013408","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"8259_CR4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22(12):1689\u20131707","journal-title":"Mov Disord"},{"issue":"3","key":"8259_CR5","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.nbd.2011.10.019","volume":"46","author":"I Ferrer","year":"2012","unstructured":"Ferrer I, Lopez-Gonzalez I, Carmona M, Dalfo E, Pujol A, Martinez A (2012) Neurochemistry and the non-motor aspects of PD. Neurobiol Dis 46(3):508\u2013526","journal-title":"Neurobiol Dis"},{"issue":"2","key":"8259_CR6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","volume":"58","author":"JE Galvin","year":"2001","unstructured":"Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58(2):186\u2013190","journal-title":"Arch Neurol"},{"issue":"9","key":"8259_CR7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/00207454.2014.961454","volume":"125","author":"L Gao","year":"2015","unstructured":"Gao L, Tang H, Nie K, Wang L, Zhao J, Gan R, Huang J, Zhu R, Feng S, Duan Z, Zhang Y, Wang L (2015) Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis. Int J Neurosci 125(9):645\u2013654","journal-title":"Int J Neurosci"},{"issue":"9","key":"8259_CR8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670\u2013676","journal-title":"Neurology"},{"issue":"11","key":"8259_CR9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","volume":"69","author":"S Hall","year":"2012","unstructured":"Hall S, Ohrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F, Nilsson C, Hakan W, Decraemer H, Nagga K, Minthon L, Londos E, Vanmechelen E, Holmberg B, Zetterberg H, Blennow K, Hansson O (2012) Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders. Arch Neurol 69(11):1445\u20131452","journal-title":"Arch Neurol"},{"issue":"1","key":"8259_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0000000000001098","volume":"84","author":"S Hall","year":"2015","unstructured":"Hall S, Surova Y, Ohrfelt A, Zetterberg H, Lindqvist D, Hansson O (2015) CSF biomarkers and clinical progression of Parkinson disease. Neurology 84(1):57\u201363","journal-title":"Neurology"},{"issue":"5","key":"8259_CR11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/mds.25857","volume":"29","author":"GM Halliday","year":"2014","unstructured":"Halliday GM, Leverenz JB, Schneider JS, Adler CH (2014) The neurobiological basis of cognitive impairment in Parkinson\u2019s disease. Mov Disord 29(5):634\u2013650","journal-title":"Mov Disord"},{"issue":"3","key":"8259_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"8259_CR13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792(7):730\u2013740","journal-title":"Biochim Biophys Acta"},{"key":"8259_CR14","first-page":"1","volume":"2","author":"FJ Jimenez-Jimenez","year":"2012","unstructured":"Jimenez-Jimenez FJ, Alonso-Navarro H, Garcia-Martin E, Agundez JA (2012) The relationship between Parkinson\u2019s disease and essential tremor: review of clinical, epidemiologic, genetic, neuroimaging and neuropathological data, and data on the presence of cardinal signs of parkinsonism in essential tremor. Tremor Other Hyperkinet Mov (N Y) 2:1\u201310","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"1","key":"8259_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-130995","volume":"38","author":"L Kaerst","year":"2014","unstructured":"Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I (2014) Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson\u2019s disease, and Alzheimer\u2019s disease. J Alzheimers Dis 38(1):63\u201373","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"8259_CR16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00415-014-7334-7","volume":"261","author":"T Kasai","year":"2014","unstructured":"Kasai T, Tokuda T, Ishii R, Ishigami N, Tsuboi Y, Nakagawa M, Mizuno T, El-Agnaf OM (2014) Increased alpha-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 261(6):1203\u20131209","journal-title":"J Neurol"},{"issue":"4","key":"8259_CR17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymeth.2012.03.016","volume":"56","author":"N Kruse","year":"2012","unstructured":"Kruse N, Schulz-Schaeffer WJ, Schlossmacher MG, Mollenhauer B (2012) Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of alpha-synuclein and other proteins in cerebrospinal fluid. Methods 56(4):514\u2013518","journal-title":"Methods"},{"issue":"4","key":"8259_CR18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/joim.12164","volume":"275","author":"X Li","year":"2014","unstructured":"Li X, Li TQ, Andreasen N, Wiberg MK, Westman E, Wahlund LO (2014) The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer\u2019s disease. J Intern Med 275(4):418\u2013427","journal-title":"J Intern Med"},{"issue":"10","key":"8259_CR19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.parkreldis.2013.06.008","volume":"19","author":"X Lim","year":"2013","unstructured":"Lim X, Yeo JM, Green A, Pal S (2013) The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies\u2014a systematic review and meta-analysis. Parkinsonism Relat Disord 19(10):851\u2013858","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"8259_CR20","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1007\/s00415-015-7837-x","volume":"262","author":"F Llorens","year":"2015","unstructured":"Llorens F, Kruse N, Schmitz M, Shafiq M, da Cunha JE, Gotzman N, Zafar S, Thune K, de Oliveira JR, Mollenhauer B, Zerr I (2015) Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD. J Neurol 262(10):2305\u20132311","journal-title":"J Neurol"},{"issue":"1\u20132","key":"8259_CR21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jns.2015.10.011","volume":"358","author":"F Llorens","year":"2015","unstructured":"Llorens F, Schmitz M, Gloeckner SF, Kaerst L, Hermann P, Schmidt C, Varges D, Zerr I (2015) Increased albumin CSF\/serum ratio in dementia with Lewy bodies. J Neurol Sci 358(1\u20132):398\u2013403","journal-title":"J Neurol Sci"},{"issue":"5","key":"8259_CR22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jalz.2015.10.009","volume":"12","author":"F Llorens","year":"2016","unstructured":"Llorens F, Schmitz M, Karch A, Cramm M, Lange P, Gherib K, Varges D, Schmidt C, Zerr I, Stoeck K (2016) Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. Alzheimers Dement 12(5):577\u2013589","journal-title":"Alzheimers Dement"},{"issue":"6","key":"8259_CR23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1001\/archneur.62.6.1004","volume":"62","author":"ED Louis","year":"2005","unstructured":"Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB (2005) Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 62(6):1004\u20131007","journal-title":"Arch Neurol"},{"issue":"3 Suppl","key":"8259_CR24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9(3 Suppl):417\u2013423","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"8259_CR25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47(5):1113\u20131124","journal-title":"Neurology"},{"issue":"2","key":"8259_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I, Krastins B, Outeiro TF, Pepivani I, Ng J, Schulz-Schaeffer W, Kretzschmar HA, McLean PJ, Trenkwalder C, Sarracino DA, Vonsattel JP, Locascio JJ, El-Agnaf OM, Schlossmacher MG (2008) Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213(2):315\u2013325","journal-title":"Exp Neurol"},{"issue":"3","key":"8259_CR27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Doring F, Trenkwalder C, Schlossmacher MG (2011) alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10(3):230\u2013240","journal-title":"Lancet Neurol"},{"issue":"3","key":"8259_CR28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neulet.2008.11.015","volume":"450","author":"A Ohrfelt","year":"2009","unstructured":"Ohrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K, Zetterberg H (2009) Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss? Neurosci Lett 450(3):332\u2013335","journal-title":"Neurosci Lett"},{"issue":"2","key":"8259_CR29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58(2):192\u2013197","journal-title":"Neurology"},{"issue":"1","key":"8259_CR30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00002826-199302000-00003","volume":"16","author":"R Pahwa","year":"1993","unstructured":"Pahwa R, Koller WC (1993) Is there a relationship between Parkinson\u2019s disease and essential tremor? Clin Neuropharmacol 16(1):30\u201335","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"8259_CR31","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.23670","volume":"26","author":"L Parnetti","year":"2011","unstructured":"Parnetti L, Chiasserini D, Bellomo G, Giannandrea D, De CC, Qureshi MM, Ardah MT, Varghese S, Bonanni L, Borroni B, Tambasco N, Eusebi P, Rossi A, Onofrj M, Padovani A, Calabresi P, El-Agnaf O (2011) Cerebrospinal fluid Tau\/alpha-synuclein ratio in Parkinson\u2019s disease and degenerative dementias. Mov Disord 26(8):1428\u20131435","journal-title":"Mov Disord"},{"issue":"13","key":"8259_CR32","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/mds.26036","volume":"29","author":"W Sako","year":"2014","unstructured":"Sako W, Murakami N, Izumi Y, Kaji R (2014) Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis. Mov Disord 29(13):1599\u20131605","journal-title":"Mov Disord"},{"issue":"5\u20138","key":"8259_CR33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13195-014-0072-3","volume":"6","author":"S Schade","year":"2014","unstructured":"Schade S, Mollenhauer B (2014) Biomarkers in biological fluids for dementia with Lewy bodies. Alzheimers Res Ther 6(5\u20138):72","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"8259_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","volume":"78","author":"NS Schoonenboom","year":"2012","unstructured":"Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78(1):47\u201354","journal-title":"Neurology"},{"issue":"2","key":"8259_CR35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-2009-0955","volume":"16","author":"PE Spies","year":"2009","unstructured":"Spies PE, Melis RJ, Sjogren MJ, Rikkert MG, Verbeek MM (2009) Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. J Alzheimers Dis 16(2):363\u2013369","journal-title":"J Alzheimers Dis"},{"key":"8259_CR36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","volume":"920","author":"MG Spillantini","year":"2000","unstructured":"Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson\u2019s disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16\u201327","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"8259_CR37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66(3):382\u2013389","journal-title":"Arch Neurol"},{"issue":"5","key":"8259_CR38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-013-1148-z","volume":"126","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Korff A, Shaw LM, Trojanowski JQ, Zhang J (2013) CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer\u2019s disease. Acta Neuropathol 126(5):683\u2013697","journal-title":"Acta Neuropathol"},{"issue":"3","key":"8259_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/CCLM.2011.086","volume":"49","author":"AC Harten van","year":"2011","unstructured":"van Harten AC, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YA, van der Flier WM, Scheltens P (2011) Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 49(3):353\u2013366","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"8259_CR40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT (2014) The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 44(4):673\u2013683","journal-title":"Psychol Med"},{"issue":"10004","key":"8259_CR41","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D (2015) Lewy body dementias. Lancet 386(10004):1683\u20131697","journal-title":"Lancet"},{"issue":"9","key":"8259_CR42","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1017\/S1041610215000447","volume":"27","author":"ZY Wang","year":"2015","unstructured":"Wang ZY, Han ZM, Liu QF, Tang W, Ye K, Yao YY (2015) Use of CSF alpha-synuclein in the differential diagnosis between Alzheimer\u2019s disease and other neurodegenerative disorders. Int Psychogeriatr 27(9):1429\u20131438","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"8259_CR43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32\u201335","journal-title":"Cancer"},{"issue":"6","key":"8259_CR44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","volume":"34","author":"J Zaccai","year":"2005","unstructured":"Zaccai J, McCracken C, Brayne C (2005) A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 34(6):561\u2013566","journal-title":"Age Ageing"},{"key":"8259_CR45","first-page":"567386","volume":"2015","author":"B Zhou","year":"2015","unstructured":"Zhou B, Wen M, Yu WF, Zhang CL, Jiao L (2015) The diagnostic and differential diagnosis utility of cerebrospinal fluid alpha-synuclein levels in Parkinson\u2019s disease: a meta-analysis. Parkinsons Dis 2015:567386","journal-title":"Parkinsons Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-016-8259-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-016-8259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T03:40:47Z","timestamp":1589686847000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-016-8259-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["8259"],"URL":"https:\/\/doi.org\/10.1007\/s00415-016-8259-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,20]]}}}